New Screening Methods in Melanoma

Aleksandra Czerw^{1

2}, Andrzej Deptała³, Olga Partyka^{1

2}, Monika Pajewska^{1

2}, Anna Badowska-Kozakiewicz³, Michał Budzik³, Katarzyna Sygit⁴, Zygmunt Kopczyński⁴, Piotr Czarnywojtek⁵, Elżbieta Cipora⁶, Magdalena Konieczny⁶, Tomasz Banaś⁷, Elżbieta Grochans⁸, Szymon Grochans⁹, Anna Maria Cybulska⁸, Daria Schneider-Matyka⁸, Ewa Bandurska¹⁰, Weronika Ciećko¹⁰, Jarosław Drobnik¹¹, Piotr Pobrotyn¹², Urszula Grata-Borkowska¹¹, Joanna Furtak-Pobrotyn¹³, Aleksandra Sierocka¹⁴, Michał Marczak¹⁵, Remigiusz Kozlowski¹⁴

Affiliations

¹ Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.
² Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
³ Department of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
⁴ Faculty of Medicine and Health Sciences, Calisia University, 62-800 Kalisz, Poland.
⁵ Polytechnic Faculty, Calisia University, 62-800 Kalisz, Poland.
⁶ Medical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.
⁷ Department of Radiotherapy, Maria Sklodowska-Curie Institute-Oncology Center, 31-115 Cracow, Poland.
⁸ Department of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
⁹ Department of Pediatric and Oncological Surgery, Urology and Hand Surgery, Faculty of Medicine and Dentistry, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
¹⁰ Center for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.
¹¹ Department of Family Medicine, Faculty of Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.
¹² Pulsantis Specialist and Rehabilitation Clinic Ltd., 53-238 Wroclaw, Poland.
¹³ Citodent Dental Center Furtak-Pobrotyn & Company Limited Partnership, 05-220 Olawa, Poland.
¹⁴ Department of Management and Logistics in Healthcare, Medical University of Lodz, 90-131 Lodz, Poland.
¹⁵ Department of Innovation, Merito University in Poznan, 61-895 Poznan, Poland.

PMID: 39766085
PMCID: PMC11674172
DOI: 10.3390/cancers16244186

Review

New Screening Methods in Melanoma

Aleksandra Czerw et al. Cancers (Basel). 2024.

. 2024 Dec 16;16(24):4186.

doi: 10.3390/cancers16244186.

Authors

Affiliations

¹ Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.
² Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
³ Department of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
⁴ Faculty of Medicine and Health Sciences, Calisia University, 62-800 Kalisz, Poland.
⁵ Polytechnic Faculty, Calisia University, 62-800 Kalisz, Poland.
⁶ Medical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.
⁷ Department of Radiotherapy, Maria Sklodowska-Curie Institute-Oncology Center, 31-115 Cracow, Poland.
⁸ Department of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
⁹ Department of Pediatric and Oncological Surgery, Urology and Hand Surgery, Faculty of Medicine and Dentistry, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
¹⁰ Center for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.
¹¹ Department of Family Medicine, Faculty of Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.
¹² Pulsantis Specialist and Rehabilitation Clinic Ltd., 53-238 Wroclaw, Poland.
¹³ Citodent Dental Center Furtak-Pobrotyn & Company Limited Partnership, 05-220 Olawa, Poland.
¹⁴ Department of Management and Logistics in Healthcare, Medical University of Lodz, 90-131 Lodz, Poland.
¹⁵ Department of Innovation, Merito University in Poznan, 61-895 Poznan, Poland.

PMID: 39766085
PMCID: PMC11674172
DOI: 10.3390/cancers16244186

Abstract

Background: The World Health Organisation reports that melanoma had an incidence of 331,722 cases worldwide in 2022, ranking it 17th on the list of the most prevalent malignancies. This disease is a threat to public health as years of potential life lost from melanoma deaths constitute an economic and social burden; it is, however, curable if detected early. This study aims to show current trends in clinical trials for melanoma screening.

Materials and methods: The analysis was conducted using data from clinicaltrials.gov. The analysis considered both interventional and observational studies on melanoma screening. Only the studies with complete and active statutes by 4 September 2024 were included in the analysis.

Results: Out of 25 studies registered in clinical trial databases regarding melanoma screening, 20% research advanced imagining techniques employing innovative machine learning algorithms, while 16% explore behavioural interventions.

Conclusions: Intensification of behavioural interventions and health promotion activities is recommended.

Keywords: MM; clinical trials; melanoma; screening.

PubMed Disclaimer

Conflict of interest statement

Author Joanna Furtak-Pobrotyn was employed by the company Citodent Dental Center Furtak-Pobrotyn &Company Limited Partnership. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

**Figure 1**
Diagram outlining the search and inclusion of studies in the analysis. a—studies with status: terminated, not yet recruiting, recruiting or other, and studies regarding treatment; b—in the period from 1 September 2019–14 September 2024.

**Figure 2**
The percentage of melanoma screening studies in the context of overall cancer research.

See this image and copyright information in PMC

References

1. Ferlay J., Ervik M., Lam F., Laversanne M., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer: Lyon, France. 2024. [(accessed on 14 September 2024)]. Available online: https://gco.iarc.who.int/today.
1. European Commission Skin Melanoma Burden in EU-27. [(accessed on 24 October 2024)]. Available online: https://publications.jrc.ec.europa.eu/repository/handle/JRC125928.
1. Wunderlich K., Suppa M., Gandini S., Lipski J., White J.M., Del Marmol V. Risk Factors and Innovations in Risk Assessment for Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma. Cancers. 2024;16:1016. doi: 10.3390/cancers16051016. - DOI - PMC - PubMed
1. Rivera A., Nan H., Li T., Qureshi A., Cho E. Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States. Cancer Epidemiol. Biomark. Prev. 2016;25:1550–1558. doi: 10.1158/1055-9965.EPI-16-0303. - DOI - PMC - PubMed
1. Marley A.R., Li M., Champion V.L., Song Y., Han J., Li X. The association between citrus consumption and melanoma risk in the UK Biobank. Br. J. Dermatol. 2021;185:353–362. doi: 10.1111/bjd.19896. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- MDPI
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

New Screening Methods in Melanoma

Affiliations

New Screening Methods in Melanoma

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

LinkOut - more resources

Full Text Sources